Dumas Agnes, Milcent Karen, Bougas Nicolas, Bejarano-Quisoboni Daniel, El Fayech Chiraz, Charreire Hélène, Oberlin Odile, Patte Catherine, Allard Julie, Thebault Eric, Boumaraf Amel, Belhout Amel, Giao Vu-Bezin, Souchard Vincent, Jackson Angela, Allodji Rodrigue, Valteau-Couanet Dominique, Dufour Christelle, Vassal Gilles, Haddy Nadia, De Vathaire Florent, Fresneau Brice
Université de Paris, ECEVE UMR 1123, INSERM (National Institute for Health and Medical Research), Paris, France.
Pediatric Department, AP-HP, Antoine Béclère Hospital, Université Paris-Saclay, Clamart, France.
Cancer. 2023 Nov 1;129(21):3476-3489. doi: 10.1002/cncr.34944. Epub 2023 Jul 11.
Long-term follow-up (LTFU) clinics have been developed but only some childhood cancer survivors (CCS) attend long-term follow-up (LTFU).
To identify factors that influence LTFU attendance.
Five-year CCS treated for a solid tumor or lymphoma in Gustave Roussy before 2000, included in the FCCSS cohort (French Childhood Cancer Survivor Study), aged >18 years and alive at the date of the LTFU Clinic opening (January 2012) were invited to a LTFU visit. Factors associated with attendance at the LTFU clinic between 2012 and 2020 were estimated using logistic regression analyses. Analyses included different types of factors: clinical (tumor characteristics, cancer treatments, late effects), medical (medical expenses were used as a proxy of survivor's health status), social (deprivation index based on census-tract data relating to income, educational level, proportion of blue-collar workers, and unemployed people living in the area of residence), and spatial (distance to the LTFU clinic).
Among 2341 CCS contacted (55% males, mean age at study, 45 years; SD ± 10 years; mean age at diagnosis, 6 years; SD ± 5 years), 779 (33%) attended at least one LTFU visit. Initial cancer-related factors associated with LTFU visit attendance were: treatment with both radiotherapy and chemotherapy (odds ratio [OR], 4.02; 95% CI, 2.11-7.70), bone sarcoma (OR, 2.43; 95% CI, 1.56-3.78), central nervous system primitive tumor (OR, 1.65; 95% CI, 1.02-2.67), and autologous hematopoietic cell transplant (OR, 2.07; 95% CI, 1.34-3.20). Late effects (OR, 1.70; 95% CI, 1.31-2.20), highest medical expenses (OR, 1.65; 95% CI, 1.22-2.22), living in the most advantaged area (OR vs. the most deprived area = 1.60; 95% CI, 1.15-2.22), and shorter distance from LTFU care center (<12 miles) also increased attendance.
Patients who are apparently healthy as well as socially disadvantaged and living far away from the center are less likely to attend LTFU care.
Among 2341 adult childhood cancer survivors contacted between 2012 and 2020, 33% attended at least one long-term follow-up visit. Clinical factors related to attendance were multimodal treatment of first cancer (combining chemotherapy and radiotherapy), stem cell transplant, type of diagnosis (bone tumor and central nervous system primitive tumor), late effects (at least one disease among second malignancy, heart disease, or stroke), and highest medical expenses. In addition, the study identified social and spatial inequalities related to attendance, with independent negative effects of distance and social deprivation on attendance, even though the medical costs related to the long-term follow-up examinations are covered by the French social security system.
长期随访(LTFU)诊所已经设立,但只有部分儿童癌症幸存者(CCS)会参加长期随访。
确定影响长期随访参与率的因素。
2000年前在古斯塔夫·鲁西研究所接受实体瘤或淋巴瘤治疗的5年生存CCS被纳入FCCSS队列(法国儿童癌症幸存者研究),年龄>18岁且在长期随访诊所开业时(2012年1月)仍存活,受邀参加一次长期随访。使用逻辑回归分析评估2012年至2020年间与长期随访诊所就诊相关的因素。分析包括不同类型的因素:临床因素(肿瘤特征、癌症治疗、晚期效应)、医疗因素(医疗费用用作幸存者健康状况的替代指标)、社会因素(基于与居住地区收入、教育水平、蓝领工人比例和失业人口相关的人口普查数据的贫困指数)和空间因素(到长期随访诊所的距离)。
在联系的2341名CCS中(55%为男性,研究时平均年龄45岁;标准差±10岁;诊断时平均年龄6岁;标准差±5岁),779人(33%)至少参加了一次长期随访。与长期随访就诊相关的初始癌症相关因素包括:同时接受放疗和化疗(比值比[OR],4.02;95%置信区间,2.11 - 7.70)、骨肉瘤(OR,2.43;95%置信区间,1.56 - 3.78)、中枢神经系统原始肿瘤(OR,1.65;95%置信区间,1.02 - 2.67)和自体造血细胞移植(OR,2.07;95%置信区间,1.34 - 3.20)。晚期效应(OR,1.70;95%置信区间,1.31 - 2.20)、最高医疗费用(OR,1.65;95%置信区间,1.22 - 2.22)、居住在最富裕地区(与最贫困地区相比的OR = 1.60;95%置信区间,1.15 - 2.22)以及距离长期随访护理中心较近(<12英里)也增加了就诊率。
表面健康、社会经济地位不利且居住在远离中心地区的患者参加长期随访护理的可能性较小。
在2012年至2020年间联系的2341名成年儿童癌症幸存者中,33%至少参加了一次长期随访。与就诊相关的临床因素包括首次癌症的多模式治疗(化疗和放疗联合)、干细胞移植、诊断类型(骨肿瘤和中枢神经系统原始肿瘤)、晚期效应(二次恶性肿瘤、心脏病或中风中的至少一种疾病)以及最高医疗费用。此外,该研究确定了与就诊相关的社会和空间不平等,距离和社会剥夺对就诊有独立的负面影响,尽管长期随访检查的医疗费用由法国社会保障系统承担。